Results 181 to 190 of about 1,067,890 (357)

The Diffusion of Science-Driven Drug Discovery: Organizational Change in Pharmaceutical Research [PDF]

Recent work linking the adoption of key organizational practices to productivity raises an important question: if adoption increases productivity so dramatically, why does adoption across an industry take so long? This paper explores this question in the
Iain Cockburn, Rebecca Henderson, Scott Stern   +2 more
core  

Heterogeneity of Rheumatoid Arthritis–Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations With Disease Outcomes

Arthritis Care &Research, EarlyView.
Objective We aimed to identify unique disease trajectories within rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999 to 2021.
Bryant R. England, Yangyuna Yang, Punyasha Roul, Tate M. Johnson, Scott M. Matson, Grant W. Cannon, Brian C. Sauer, Jeffrey R. Curtis, Joshua F. Baker, Ted R. Mikuls   +9 more
wiley   +1 more source

Advances in Pharmaceutical Science in Electrochemotherapy: A Tribute to Prof. Jolanta Saczko. [PDF]

Pharmaceuticals (Basel)
Rembiałkowska N, Kulbacka J.
europepmc   +1 more source

Journal of Chemical and Pharmaceutical Sciences

, 2019

openalex   +1 more source

Corrections for “Thermodynamic Modeling of Activity Coefficient and Prediction of Solubility. Parts 1 and 2,” Journal of Pharmaceutical Sciences 95(4) 2006, pp 790–809 [PDF]

, 2013
Mahmoud Mirmehrabi, Sohrab Rohani
openalex   +1 more source

Long‐Term Opioids in Gout: A Matched Cohort Study From the Veterans Health Administration

Arthritis Care &Research, EarlyView.
Objective Though used frequently to treat flare, risk of long‐term opioid exposure in gout has not been well defined. In this study, we examined the hypothesis that people with gout are more likely than individuals without gout to be prescribed long‐term opioids over time.
Lindsay N. Helget, Bryant R. England, Punyasha Roul, Harlan Sayles, Tuhina Neogi, James R. O'Dell, Joshua F. Baker, Ted R. Mikuls   +7 more
wiley   +1 more source

Nanosponge: A promising and intriguing strategy in medical and pharmaceutical Science. [PDF]

Heliyon
Garg A, Lai WC, Chopra H, Agrawal R, Singh T, Chaudhary R, Dubey BN.   +6 more
europepmc   +1 more source

Journal of Allied Pharmaceutical Sciences

, 2018

openalex   +1 more source

Virtual or In‐Person: Does It Matter? Comparing Pain, Function, Quality of Life, Self‐Efficacy, and Physical Function Outcomes of Virtual, Hybrid, and In‐Person Education and Exercise Program Participants

Arthritis Care &Research, EarlyView.
Objective This study aimed to determine if program format (in‐person, virtual, or hybrid) results in differences in 3‐month outcomes of pain, function, quality of life, self‐efficacy, and chair stands in a hip/knee osteoarthritis‐management program. Methods A secondary analysis of the Good Life with osteoArthritis in Denmark (GLA:D) Canada database was
Jill Van Damme, Vanina Dal Bello‐Haas, Ayse Kuspinar, Patricia Strachan, Michael Zywiel, James Young, Rhona McGlasson, Lisa C. Carlesso   +7 more
wiley   +1 more source

Microbial contamination in the environment of a clinic for small animals at the University of Veterinary and Pharmaceutical Sciences in Brno [PDF]

, 1994
András Fiser, V. Živnová
openalex   +1 more source